240 related articles for article (PubMed ID: 32362890)
1. Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life.
Martin Aispuro P; Ambrosis N; Zurita ME; Gaillard ME; Bottero D; Hozbor DF
Front Microbiol; 2020; 11():723. PubMed ID: 32362890
[TBL] [Abstract][Full Text] [Related]
2. Impact of maternal whole-cell or acellular pertussis primary immunization on neonatal immune response.
Martin Aispuro P; Bottero D; Zurita ME; Gaillard ME; Hozbor DF
Front Immunol; 2023; 14():1192119. PubMed ID: 37435078
[TBL] [Abstract][Full Text] [Related]
3. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T
Wilk MM; Borkner L; Misiak A; Curham L; Allen AC; Mills KHG
Emerg Microbes Infect; 2019; 8(1):169-185. PubMed ID: 30866771
[TBL] [Abstract][Full Text] [Related]
4. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
[TBL] [Abstract][Full Text] [Related]
5. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
Banus S; Stenger RM; Gremmer ER; Dormans JA; Mooi FR; Kimman TG; Vandebriel RJ
BMC Immunol; 2008 May; 9():21. PubMed ID: 18498620
[TBL] [Abstract][Full Text] [Related]
6. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.
Misiak A; Leuzzi R; Allen AC; Galletti B; Baudner BC; D'Oro U; O'Hagan DT; Pizza M; Seubert A; Mills KHG
Vaccine; 2017 Sep; 35(39):5256-5263. PubMed ID: 28823618
[TBL] [Abstract][Full Text] [Related]
7. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.
van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM
Front Immunol; 2018; 9():51. PubMed ID: 29416544
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the immune response induced by pertussis OMVs-based vaccine.
Bottero D; Gaillard ME; Zurita E; Moreno G; Martinez DS; Bartel E; Bravo S; Carriquiriborde F; Errea A; Castuma C; Rumbo M; Hozbor D
Vaccine; 2016 Jun; 34(28):3303-9. PubMed ID: 27151884
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against
Jiang W; Wang X; Su Y; Cai L; Li J; Liang J; Gu Q; Sun M; Shi L
Front Immunol; 2022; 13():878832. PubMed ID: 35493458
[TBL] [Abstract][Full Text] [Related]
10. Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency.
Gaillard ME; Bottero D; Zurita ME; Carriquiriborde F; Martin Aispuro P; Bartel E; Sabater-Martínez D; Bravo MS; Castuma C; Hozbor DF
Front Immunol; 2017; 8():1099. PubMed ID: 28932228
[TBL] [Abstract][Full Text] [Related]
11. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
[TBL] [Abstract][Full Text] [Related]
12. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
[TBL] [Abstract][Full Text] [Related]
13. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.
Gaillard ME; Bottero D; Errea A; Ormazábal M; Zurita ME; Moreno G; Rumbo M; Castuma C; Bartel E; Flores D; van der Ley P; van der Ark A; F Hozbor D
Vaccine; 2014 Feb; 32(8):931-7. PubMed ID: 24397896
[TBL] [Abstract][Full Text] [Related]
14. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
van der Lee S; Sanders EAM; Berbers GAM; Buisman AM
Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041
[TBL] [Abstract][Full Text] [Related]
15. Acellular Pertussis Vaccine Inhibits
Holubová J; Staněk O; Brázdilová L; Mašín J; Bumba L; Gorringe AR; Alexander F; Šebo P
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33228165
[No Abstract] [Full Text] [Related]
16. Immunological Distinctions between Acellular and Whole-Cell Pertussis Immunizations of Baboons Persist for at Least One Year after Acellular Vaccine Boosting.
Cole LE; Zhang J; Pacheco KM; Lhéritier P; Anosova NG; Piolat J; Zheng L; Reveneau N
Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33276673
[TBL] [Abstract][Full Text] [Related]
17. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies.
Polewicz M; Gracia A; Garlapati S; van Kessel J; Strom S; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
Vaccine; 2013 Jun; 31(31):3148-55. PubMed ID: 23684829
[TBL] [Abstract][Full Text] [Related]
18. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
[No Abstract] [Full Text] [Related]
19. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
[TBL] [Abstract][Full Text] [Related]
20. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination.
Prelog M; Almanzar G; Rieber N; Ottensmeier B; Zlamy M; Liese J
Vaccine; 2013 Jan; 31(2):387-93. PubMed ID: 23142306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
